Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Thürmann PA"'
Autor:
Wurmbach VS, Schmidt SJ, Lampert A, Bernard S, Faller CK, Thürmann PA, Haefeli WE, Seidling HM
Publikováno v:
Patient Preference and Adherence, Vol Volume 15, Pp 2479-2488 (2021)
Viktoria S Wurmbach,1,2 Steffen J Schmidt,3 Anette Lampert,1,2 Simone Bernard,3 Christine K Faller,1,2 Petra A Thürmann,3,4 Walter E Haefeli,1,2 Hanna M Seidling1,2 On behalf of HIOPP-6 Consortium1Department of Clinical Pharmacology and Pharmacoepid
Externí odkaz:
https://doaj.org/article/8f2b0ca939f140518874dba9ca3d91e4
Publikováno v:
27. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20201126-20201126; sine loco [digital]; DOC20gaa06 /20201123/
Background: A large number of elderly, frail patients are exposed to polypharmacy, drug interactions and potentially inappropriate medication. Particular attention is paid to drugs with anticholinergic and sedative effects, which can lead to adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9f0b92e3101900e7c6f513d26abe32
Publikováno v:
26. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20191121-20191122; Bonn/Bad Godesberg; DOC19gaa16 /20191119/
Background: Lists of potentially inappropriate medication (PIM) support clinicians, other healthcare professionals and patients by alerting them to medicines whose risks may outweigh their benefits specifically in older patients. In addition, such li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074f1827c414843fbfab2ebd955628ee
Autor:
Dormann, H, Maas, R, Eickhoff, C, Müller, U, Schulz, M, Brell, D, Thürmann, PA, MetropolMediplan 2016, Modellregion Erfurt, PRIMA
Since 1 October 2016, all legally insured persons are entitled to a nationwide medication plan (BMP) under certain conditions (according to § 31a SGB V, E-Health Law). The catalogue of measures of the 3rd Action Plan 2013-2015 for the improvement of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::0e8c30cc057d86329fdfc49da4b05eec
https://hdl.handle.net/10453/161665
https://hdl.handle.net/10453/161665
Publikováno v:
23. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20161124-20161125; Bochum; DOC16gaa04 /20161123/
Background: Demographic changes associated with increasing age and multimorbidity pose challenges to health care professionals. Guideline-adapted treatment of multimorbid geriatric patients often leads to polypharmacy [ref:1]. Drug related problems (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a9303cf702b65abfbdd1cf8310d5f6
Autor:
Thürmann Pa, Collette D
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 127:1025-1028
Publikováno v:
European Journal of Clinical Pharmacology. 57:235-241
Objective: Intravenous immunoglobulin (IVIG) preparations are derived from human pooled plasma and should fulfil high standards of purity and viral safety. Introduction of additional purification steps, however, may result in modulation of the biolog
Autor:
Steioff A, Thürmann Pa
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 39:185-191
When considering drug therapy in pregnancy, the risk of treatment for the embryo/fetus has to be weighed against the risk to the mother and the child of carrying out no treatment. This is of particular relevance in certain conditions like diabetes, e
Publikováno v:
European Journal of Clinical Pharmacology. 49:237-242
In two independent trials 10 and 12 healthy volunteers received the novel intravenous immunoglobulin (IVIG) preparations BT 511 and BT 507, respectively. BT 511 contains 5 g human plasma proteins per 100 ml, more than 95% of which are immunoglobulins
Publikováno v:
19. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20121122-20121123; Jena; DOC12gaa14 /20121114/
20. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20131205-20131206; Düsseldorf; DOC13gaa23 /20131125/
20. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20131205-20131206; Düsseldorf; DOC13gaa23 /20131125/
Hintergrund: Multimedikation ist ein häufig feststellbares Phänomen in der Arzneimitteltherapie, das in letzter Zeit vermehrt Aufmerksamkeit erhalten hat [ref:1]. Es betrifft nicht ausschließlich ältere medikamentös therapierte Menschen, tritt b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca186184557a1dfc2d870657c49d25f8